Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of ...
Hundreds of medcines have become hard or impossible to obtain as the medicine supply crisis deepens - including drugs for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback